{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:28:01Z","timestamp":1788571681244,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.cmi.2022.11.014","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T10:19:42Z","timestamp":1669285182000},"page":"538.e7-538.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients"],"prefix":"10.1016","volume":"29","author":[{"given":"Carla","family":"L\u00f3pez-Causap\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhize","family":"Maruri-Aransolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda A.","family":"Gomis-Font","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Penev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Garc\u00eda","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"de Dios Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa del","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Cant\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2022.11.014_bib1","series-title":"European center for disease prevention and control. Annual epidemiological report for 2017","article-title":"Healthcare-associated infections acquired in intensive care units","year":"2019"},{"key":"10.1016\/j.cmi.2022.11.014_bib2","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1126\/science.288.5469.1251","article-title":"High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection","volume":"288","author":"Oliver","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.cmi.2022.11.014_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3389\/fmicb.2018.00685","article-title":"The versatile mutational resistome of Pseudomonas aeruginosa","volume":"9","author":"L\u00f3pez-Causap\u00e9","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2022.11.014_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2022.11.014_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhin.2019.06.005","article-title":"Incremental clinical and economic burden of suspected respiratory infections due to multi-drug-resistant Pseudomonas aeruginosa in the United States","volume":"103","author":"Tabak","year":"2019","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2022.11.014_bib6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2022.11.014_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00031-19","article-title":"Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections","volume":"32","author":"Horcajada","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2022.11.014_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106196","article-title":"Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired \u03b2-lactamases: 2020 update","volume":"56","author":"Del Barrio-Tofi\u00f1o","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2022.11.014_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drup.2015.08.002","article-title":"The increasing threat of Pseudomonas aeruginosa high-risk clones","volume":"21\u201322","author":"Oliver","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.cmi.2022.11.014_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00019-18","article-title":"Epidemiology, biology, and impact of clonal Pseudomonas aeruginosa infections in cystic fibrosis","volume":"31","author":"Parkins","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2022.11.014_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.addr.2014.11.017","article-title":"Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients","volume":"85","author":"Ciofu","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cmi.2022.11.014_bib12","doi-asserted-by":"crossref","first-page":"10714","DOI":"10.1073\/pnas.1721270115","article-title":"Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions","volume":"115","author":"Schick","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cmi.2022.11.014_bib13","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.1128\/JB.01147-08","article-title":"Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation","volume":"190","author":"Mena","year":"2008","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.cmi.2022.11.014_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41579-020-00477-5","article-title":"Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis","volume":"19","author":"Rossi","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2022.11.014_bib15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/14787210.2022.2071701","article-title":"Treatment of carbapenem-resistant Pseudomonas aeruginosa infections: a case for cefiderocol","volume":"20","author":"Canton","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cmi.2022.11.014_bib16","doi-asserted-by":"crossref","first-page":"S538","DOI":"10.1093\/cid\/ciz826","article-title":"Cefiderocol: discovery, chemistry, and in\u00a0vivo profiles of a novel siderophore cephalosporin","volume":"69","author":"Sato","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2022.11.014_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ng.3148","article-title":"Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis","volume":"47","author":"Marvig","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.cmi.2022.11.014_bib18","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1038\/s41598-017-05621-5","article-title":"Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone","volume":"7","author":"L\u00f3pez-Causap\u00e9","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2022.11.014_bib19","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.cmi.2021.05.011","article-title":"Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis","volume":"27","author":"Cortes-Lara","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2022.11.014_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071001","article-title":"Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection","volume":"8","author":"L\u00f3pez-Causap\u00e9","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2022.11.014_bib21","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1128\/JCM.05478-11","article-title":"Emergence of a mutL mutation causing multilocus sequence typing-pulsed-field gel electrophoresis discrepancy among Pseudomonas aeruginosa isolates from a cystic fibrosis patient","volume":"50","author":"Garc\u00eda-Castillo","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2022.11.014_bib22","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1128\/AAC.01024-08","article-title":"Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"53","author":"Vettoretti","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.11.014_bib23","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/jac\/dkx424","article-title":"Mechanisms leading to in\u00a0vivo ceftolozane\/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa","volume":"73","author":"Fraile-Ribot","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2022.11.014_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab311","article-title":"Cefiderocol activity against clinical Pseudomonas aeruginosa isolates exhibiting ceftolozane-tazobactam resistance","volume":"8","author":"Simner","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2022.11.014_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1473-3099(20)30731-3","article-title":"Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial","volume":"21","author":"Wunderink","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2022.11.014_bib26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2022.11.014_bib27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1089\/mdr.2021.0180","article-title":"Mechanisms of reduced susceptibility to cefiderocol among isolates from the CREDIBLE-CR and APEKS-NP clinical trials","volume":"28","author":"Nordmann","year":"2022","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.cmi.2022.11.014_bib28","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1128\/JB.187.10.3289-3292.2005","article-title":"Pyoverdine receptor: a case of positive Darwinian selection in Pseudomonas aeruginosa","volume":"187","author":"T\u00fcmmler","year":"2005","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.cmi.2022.11.014_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00097-18","article-title":"TonB-dependent receptor repertoire of Pseudomonas aeruginosa for uptake of siderophore-drug conjugates","volume":"62","author":"Luscher","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.11.014_bib30","article-title":"In\u00a0vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against gram-negative bacteria","volume":"62","author":"Ito","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.11.014_bib31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciab511","article-title":"Rapid development of cefiderocol resistance in carbapenem-resistant Enterobacter cloacae during therapy is associated with heterogeneous mutations in the catecholate siderophore receptor cirA","volume":"74","author":"Klein","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2022.11.014_bib32","doi-asserted-by":"crossref","first-page":"dlac011","DOI":"10.1093\/jacamr\/dlac011","article-title":"Evolution of cefiderocol resistance in Stenotrophomonas maltophilia using in\u00a0vitro serial passage techniques","volume":"4","author":"Werth","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.cmi.2022.11.014_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.01779-21","article-title":"In\u00a0vitro evolution of cefiderocol resistance in an NDM-producing Klebsiella pneumoniae due to functional loss of cirA","volume":"9","author":"McElheny","year":"2021","journal-title":"Microbiol Spectr"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22005869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22005869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:33:57Z","timestamp":1761118437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X22005869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1198743X22005869"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2022.11.014","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2022.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}